STIOLTO will cost different prices depending on various factors such as the pharmacy or retailer where you intend to purchase. Retail prices for STIOLTO are typically higher than prices offered by pharmacies that participate in prescription drug plans. However, the drug’s cost without insurance can be quite steep.
According to GoodRx, a website that tracks drug prices, as of 2021, the average cost of STIOLTO inhaler was around $450. This price is for a 30-day supply of 60 doses, which amounts to roughly $7.50 per dosage. This means that if you need to use the drug regularly, you may have to pay hundreds of dollars every month.
It is essential to note that these prices may vary depending on the location and whether there are any discounts available to a patient. Some pharmacies offer discounts when you pay in cash, or when you use discount cards or coupons, which can significantly slash the cost. Additionally, many manufacturers and drug assistance programs offer financial assistance to help reduce out-of-pocket expenses for people who cannot afford their medication.
Such options may come in the form of free drug samples, patient assistance programs, and co-pay reductions.
The cost of STIOLTO inhaler without insurance can be quite steep, ranging anywhere from $400 to $500 for a 30-day supply. However, several options can help lower the cost, such as using coupons, discount cards or participating in manufacturer and drug assistance programs. It is advisable always to research the options available to ensure that you obtain the best possible deal.
Table of Contents
How can I get STIOLTO cheaper?
STIOLTO is a prescription medication used to treat chronic obstructive pulmonary disease (COPD). While the cost of STIOLTO can be high, there are several ways to obtain the medication at a more affordable price. Here are some options:
1. Look for generic versions of the medication: Currently, there are no generic versions of STIOLTO available in the market. However, keep an eye on the pharmaceutical market as this may change in the future. When a generic version of a drug becomes available, the cost of the medication usually drops significantly.
2. Apply for patient assistance programs: Drug manufacturers often offer patient assistance programs to those who meet their eligibility criteria. These programs can provide free or discounted medication to eligible individuals who cannot afford to pay for it. To find out if you qualify for a patient assistance program for STIOLTO, check the manufacturer’s website or speak with your healthcare provider.
3. Use a prescription discount card: Prescription discount cards are available through many different companies and can help you save on the cost of STIOLTO. These cards can be used at most pharmacies and can provide discounts of up to 80% off the retail price of medication. Some prescription discount cards charge an annual fee, so it is essential to read the terms and conditions of the program carefully.
4. Ask for a 90-day supply from your healthcare provider: If you require long-term treatment with STIOLTO, ask your healthcare provider to prescribe a 90-day supply of the medication. This can sometimes result in lower costs compared to purchasing the medication in smaller quantities.
5. Check for online pharmacies overseas: While it is essential to be cautious when buying medication from an online pharmacy, some overseas pharmacies offer significantly lower prices on STIOLTO. Ensure that the pharmacy is accredited and licensed by a reputable regulatory authority before making a purchase.
There are several ways to obtain STIOLTO at a more affordable price. Speak with your healthcare provider or pharmacist for guidance on the best approach to save on the cost of this medication.
Is there a generic for Stiolto Respimat?
Yes, there is a generic version of Stiolto Respimat available in the market. It is marketed as Tiotropium Bromide and Olodaterol Respimat and is manufactured by various pharmaceutical companies. This generic medication contains the same active ingredients as Stiolto Respimat, which are tiotropium bromide and olodaterol.
Tiotropium bromide is a long-acting anticholinergic bronchodilator while olodaterol is a long-acting beta-agonist bronchodilator. Both work by relaxing the muscles in the airways, which makes it easier for the individual to breathe. These medications are used to treat chronic obstructive pulmonary disease (COPD), a progressive lung disease that causes breathing difficulties.
The generic version of Stiolto Respimat is frequently prescribed by doctors as it is more affordable than the branded medication. However, it is essential to note that not all generic drugs are equal in quality, and it is important to buy from a reputable manufacturer to obtain the best quality medication.
Before switching to any generic medication, it is crucial to consult with your doctor, who can advise you on the most suitable treatment options for managing your COPD symptoms. Your doctor can also answer any questions you may have about the generic medication and provide you with useful information on how to take it safely and effectively.
A generic version of Stiolto Respimat is available and is a more cost-effective alternative for people with COPD who require long-term medication. With proper medical guidance, patients can safely use the generic Stiolto Respimat to manage their symptoms and improve their quality of life.
What tier is STIOLTO?
STIOLTO is a prescription medicine that is used to treat Chronic Obstructive Pulmonary Disease (COPD) in adult patients. It is a combination of two active ingredients, tiotropium and olodaterol, and is taken through an inhaler device.
In terms of classification or tier, STIOLTO is known as a combination long acting bronchodilator, which is categorized as a Maintenance Inhaler. Maintenance Inhalers are typically used to control symptoms of COPD and prevent flare-ups or exacerbations.
In the United States, medications are classified into different tiers based on the type of insurance coverage they have. These tiers determine the out-of-pocket cost that patients have to bear when purchasing the medication. Tiers are usually assigned by individual insurance companies, and therefore, can vary from one insurance plan to another.
For STIOLTO, its tier classification would depend on the coverage provided by the patient’s respective insurance provider. Generally, it is considered to be a tier 3 prescription drug, which means that it would be more expensive than tier 1 and tier 2 medication options.
However, it is essential to note that tier classification is not the only factor determining the cost of medication. Other factors, such as the amount of medication needed, the length of treatment, and the availability of generic or alternative medications, can also affect the cost.
Stiolto is a Maintenance Inhaler used for the treatment of COPD, and its tier classification would depend on the patient’s insurance provider. As a tier 3 medication, it may be more expensive than tier 1 and 2 options. It is crucial for patients to discuss medication costs and coverage with their healthcare provider and insurance provider to optimize treatment options.
How much does Spiriva Respimat cost without insurance?
Spiriva Respimat is a prescription medication that is primarily used for treating chronic obstructive pulmonary disease (COPD), a respiratory condition that causes breathing difficulties. It contains the active ingredient tiotropium bromide, which helps to open up the airways and improve breathing.
The cost of Spiriva Respimat without insurance can vary depending on several factors such as location, pharmacy, dosage, and quantity. The retail price of this medication can range from $350 to $450 for a single inhaler. It is essential to note that this price may not reflect discounts, coupons or manufacturer rebates which may be available.
Several online resources and drug price comparison websites can be a good starting point to check the average cost of Spiriva Respimat in your area. However, the price listed on these sites is just a rough estimate and can vary based on various factors.
It is also important to consider other factors such as the availability of generic alternatives, patient assistance programs, and insurance coverage before finalizing the purchase. Patients are advised to talk to their healthcare provider, pharmacist, or insurance company before purchasing Spiriva Respimat or making any changes in their medication.
It’s always best to have proper consultation and expert advice before taking such medications to ensure their safety and effectiveness.
Is Stiolto respimat better than Spiriva Respimat?
Both Stiolto Respimat and Spiriva Respimat are inhalers used to treat chronic obstructive pulmonary disease (COPD). Stiolto Respimat contains two active ingredients, tiotropium and olodaterol, while Spiriva Respimat contains only tiotropium. Both drugs are anticholinergic bronchodilators that help to relax the muscles in the airways, allowing the person with COPD to breathe more easily.
Numerous studies have compared Stiolto Respimat and Spiriva Respimat in terms of their efficacy and safety. One study, published in the European Respiratory Journal in 2016, found that Stiolto Respimat provided greater improvements in lung function and reduced COPD exacerbations compared to Spiriva Respimat.
Another study, published in the International Journal of Chronic Obstructive Pulmonary Disease in 2018, similarly found that Stiolto Respimat was more effective than Spiriva Respimat in improving lung function and reducing exacerbations.
However, it is important to note that individual responses to the drugs may vary, and some people may find better relief with Spiriva Respimat. Both drugs have the potential to cause side effects, such as dry mouth, blurred vision, and urinary retention.
The decision to use Stiolto Respimat or Spiriva Respimat should be based on an individual’s specific medical needs, taking into account factors such as age, medical history, and other medications being taken. It is important to discuss the potential benefits and drawbacks of each medication with a healthcare provider before making a decision.
Can you take albuterol with Stiolto?
Albuterol and Stiolto are both medications commonly used for treating respiratory problems. Albuterol is a short-acting bronchodilator that helps to open up airways and make breathing easier, while Stiolto is a combination of two long-acting bronchodilators, namely tiotropium and olodaterol, that helps to relax the airway muscles and reduce inflammation.
Taking albuterol and Stiolto together can be done but should only be done with the advice of a healthcare professional. It is not uncommon for people with respiratory problems to be prescribed both medications, as they perform different actions and can be used in conjunction as part of a comprehensive treatment plan.
However, it’s essential to remember that both of these medications can cause side-effects, and taking them together could increase the risk of experiencing these side-effects. For example, using albuterol and Stiolto simultaneously can cause an increase in heart rate and blood pressure. It may also cause nervousness, tremors, and other symptoms associated with the use of beta-agonists.
Additionally, the dose and frequency of the medication should be carefully monitored when using both together as they both can increase the potential for drug interactions. Therefore, it is imperative to speak with a doctor before taking albuterol with Stiolto to ensure that it is safe and does not pose any risk to health.
Overall, while taking albuterol and Stiolto together can be appropriate for those with respiratory problems, it is crucial to have the guidance of a healthcare professional and understand the benefits, risks, and side-effects that may arise.
Can Stiolto raise blood pressure?
Stiolto is a combination medication consisting of two active ingredients, Tiotropium and Olodaterol, which are bronchodilators used to treat chronic obstructive pulmonary disease (COPD).
A possible side effect of Stiolto is an increase in blood pressure, although this effect is not common. The package insert for Stiolto suggests that patients with underlying hypertension should have their blood pressure monitored closely while taking the medication.
However, it is important to note that not everyone who takes Stiolto will experience this side effect. Blood pressure changes are individual and dependent on a variety of factors including genetics, underlying medical conditions, and lifestyle habits such as diet and exercise.
Therefore, if you are experiencing any discomfort, changes or abnormal symptoms, of any kind, while taking Stiolto, it is important to consult with your healthcare provider. Your healthcare provider will be able to provide you with tailored guidance on the use of Stiolto, and monitor your health closely to ensure that you are receiving the best possible treatment.
It is also important to continue to monitor your blood pressure regularly and to discuss any concerns you may have with your healthcare provider. By doing so, you can help to increase the effectiveness of your treatment plan while minimizing the risk of developing any adverse side effects from the use of Stiolto.
What is the substitute for Spiriva?
Spiriva is a medication used to treat Chronic Obstructive Pulmonary Disease (COPD) by relaxing the muscles in the airways and increasing airflow to the lungs. It is classified as a long-acting anticholinergic bronchodilator and is available in two forms – a capsule inhaler and a Respimat inhaler.
If you are looking for an alternative medication to Spiriva, there are several other treatments available that your healthcare provider may recommend. The most common one is a group of medications called beta-agonists. These drugs work similarly to Spiriva by relaxing the airways and making it easier to breathe.
Examples of beta-agonists include albuterol (Ventolin), salmeterol (Serevent), and formoterol (Foradil).
Another alternative to Spiriva is a class of medications called corticosteroids. These drugs are used to reduce inflammation and swelling in the airways, which can help improve breathing. Examples of corticosteroids include fluticasone (Flovent) and budesonide (Pulmicort).
In some cases, your healthcare provider may recommend a combination of medications to treat your COPD. For example, they may prescribe a combination of a beta-agonist and a corticosteroid, such as Advair or Symbicort. Another option may be to combine a beta-agonist with a long-acting muscarinic antagonist (LAMA), such as Anoro.
It is important to note that the type of medication prescribed by your healthcare provider will depend on the severity of your COPD symptoms and other factors, such as your medical history, age, and overall health. Therefore, it is essential to consult with your doctor before switching to an alternative medication or self-treating your COPD.
What drug can replace Spiriva?
Spiriva is a prescription medication used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works to relax the muscles in the airways, making it easier to breathe. While Spiriva is a highly effective medication, there are other drugs that can be used as a replacement in certain situations.
The choice of a replacement drug for Spiriva will depend on a variety of factors, including the severity and type of COPD, the patient’s overall health, and any other medications they may be taking. Some possible options for replacing Spiriva include long-acting beta-agonists (LABAs), inhaled corticosteroids (ICSs), and combination drugs that contain both a LABA and an ICS.
One type of LABA that may be used in place of Spiriva is formoterol, which works by relaxing the muscles in the airways and improving breathing. This medication is typically used as a maintenance treatment in patients with COPD and is taken twice daily via inhaler.
Another option is an ICS such as fluticasone, which works to reduce inflammation in the airways, making it easier to breathe. This medication is often used in combination with a LABA and is taken once or twice daily via inhaler.
Combination drugs that contain both a LABA and an ICS may also be used as a replacement for Spiriva. One example of this is Advair, which contains fluticasone and salmeterol. This medication is taken twice daily via inhaler and is effective at reducing symptoms and improving lung function in patients with COPD.
It is important to note that any replacement drug for Spiriva should be prescribed by a healthcare provider and should only be used under their guidance. Patients with COPD should work closely with their healthcare team to develop a treatment plan that meets their specific needs and helps them manage their symptoms effectively.
What inhaler is comparable to Spiriva Respimat?
Spiriva Respimat is a popular inhaled medication that is primarily used to treat chronic obstructive pulmonary disease (COPD). It contains the active ingredient tiotropium, which helps to relax the muscles in the airways and improve breathing.
There are several other inhalers available on the market that are comparable to Spiriva Respimat. One such inhaler is the HandiHaler, which also contains tiotropium and is marketed under the brand name Spiriva HandiHaler. This inhaler delivers the medication in a dry powder form, unlike the Respimat which delivers the medication as a mist.
Another option is Anoro Ellipta, an inhaler that contains two active ingredients, umeclidinium and vilanterol. It is used to treat both COPD and asthma, and works by relaxing the muscles in the airways and improving airflow.
Additionally, the inhaler Trelegy Ellipta is also comparable to Spiriva Respimat. It contains three active ingredients, fluticasone, umeclidinium, and vilanterol, and is used to treat severe COPD. This inhaler is unique because it contains both a steroid and a long-acting bronchodilator, which provide continuous symptom relief for up to 24 hours.
It is important to note that while these inhalers are comparable to Spiriva Respimat, they may not be suitable for everyone. Patients should always consult with their doctor or a healthcare professional before switching to a new inhaler or medication. They should also follow the manufacturer’s instructions for use and be aware of any potential side effects.
How good is Stiolto respimat?
Stiolto Respimat is a combination medication consisting of two bronchodilators, tiotropium, and olodaterol. It is used for the management of chronic obstructive pulmonary disease (COPD) in adults. The medication is inhaled through a special inhaler device, Respimat, which uses a soft mist to deliver the medication into the lungs.
When it comes to the effectiveness of Stiolto Respimat, its success rate varies from person to person, depending on their overall health and the severity of their COPD. However, clinical trials have shown that Stiolto Respimat is useful in reducing the number of exacerbations experienced by COPD patients.
One study, called the TONADO clinical trial, showed that Stiolto Respimat was more effective in reducing the number of exacerbations, improving lung function, and reducing symptoms compared to tiotropium alone. The study also indicated that Stiolto Respimat was well-tolerated and caused minimal side effects.
Another study, called the DYNAGITO trial, compared the effects of Stiolto Respimat to Spiriva Respimat, which contains only tiotropium. The study determined that the patients using Stiolto Respimat had a lower risk of experiencing COPD exacerbations compared to those using Spiriva Respimat.
In general, Stiolto Respimat has been shown to be a safe and effective treatment for COPD, especially in preventing exacerbations. However, like any medication, it may not work for everyone or cause side effects in some individuals. Therefore, it is important to consult with one’s healthcare provider before starting any new medication to determine whether it is an appropriate option for them.
How much does Stiolto Respimat cost at Walmart?
Stiolto Respimat is a prescription medication that is used to treat chronic obstructive pulmonary disease (COPD) in patients who require both tiotropium and olodaterol. It is a combination medication that works by relaxing the muscles in the airways and improving airflow to the lungs.
The cost of Stiolto Respimat can vary depending on a few factors, such as your insurance coverage, the dosage prescribed, and the pharmacy you purchase it from. At Walmart, the cost of the medication may also vary depending on the location and availability of the drug.
To get an accurate price for the medication, you may want to speak to your doctor or pharmacist. They can provide you with information on the cost of the medication at Walmart or other pharmacies in your area and help you determine if there are any cost-saving options available.
Additionally, you may want to check if there are any coupons or discounts available that can help reduce the cost of the medication. Some manufacturers offer coupons or financial assistance programs to help patients afford their medications, and your doctor or pharmacist can provide you with information on these programs.
The cost of Stiolto Respimat at Walmart can vary depending on several factors. If you need this medication, you should speak to your doctor or pharmacist to get an accurate price and determine if there are any cost-saving options available to you.
Is Anoro Ellipta better than Stiolto Respimat?
Anoro Ellipta and Stiolto Respimat are both medications used to treat Chronic Obstructive Pulmonary Disease (COPD). Anoro Ellipta contains two active ingredients – umeclidinium and vilanterol, while Stiolto Respimat contains two active ingredients – tiotropium and olodaterol.
The effectiveness of these medications may vary depending on the severity of COPD and other individual factors. However, based on clinical studies and trials, Anoro Ellipta has been found to be a more effective medication for COPD than Stiolto Respimat.
One of the reasons for Anoro Ellipta’s superiority over Stiolto Respimat is due to its dual mode of action. Umeclidinium, one of the active ingredients in Anoro Ellipta, is a long-acting muscarinic antagonist (LAMA) that helps to relax the airways, while vilanterol, the other active ingredient, is a long-acting beta-agonist (LABA) that helps to open up the airways.
The combination of these two medications works together to provide better relief from COPD symptoms.
In contrast, Stiolto Respimat contains two LAMAs – tiotropium and olodaterol. While LAMAs are effective in treating COPD, they may not provide as much relief as the combination of a LAMA and LABA that Anoro Ellipta offers.
Another factor that sets Anoro Ellipta apart from Stiolto Respimat is their ease of use. Anoro Ellipta is a dry powder inhaler that is easy to use and does not require coordination of breathing and pressing the inhaler button. On the other hand, Stiolto Respimat is a soft mist inhaler that requires careful coordination for optimal effectiveness.
Both Anoro Ellipta and Stiolto Respimat are effective medications for COPD but based on the available evidence, Anoro Ellipta appears to be a better option due to its dual mode of action, ease of use and greater relief from symptoms. However, it is important to consult a healthcare provider to determine the most suitable medication based on individual factors and medical history.
Is STIOLTO same as Anoro?
STIOLTO and Anoro are both medications used for the treatment of chronic obstructive pulmonary disease (COPD) in adults. However, they are not exactly the same medication.
STIOLTO is a combination of two active ingredients, tiotropium, and olodaterol. Tiotropium is a long-acting anticholinergic medication that relaxes the muscles in the airways and helps to keep the air passages open. Olodaterol, on the other hand, is a long-acting beta-agonist medication that also relaxes the muscles in the airways, making it easier for individuals to breathe.
STIOLTO is prescribed to improve lung function and reduce the symptoms of COPD, including shortness of breath, coughing, and wheezing.
Anoro, on the other hand, is also a combination medication, but it contains two different active ingredients, umeclidinium and vilanterol. Umeclidinium is also a long-acting anticholinergic medication, while vilanterol is a long-acting beta-agonist medication. Anoro is used to improve lung function or decrease the symptoms of COPD, such as breathing difficulties, coughing, and chest tightness.
While both STIOLTO and Anoro are medications used for treating COPD, they have different active ingredients and thus work in slightly different ways. Patients should always consult with their healthcare providers to determine which medication is right for them and to ensure that they understand the proper usage and dosage for each medication.
